European journal of oncology nursing : the official journal of European Oncology Nursing Society · 2026
Prioritizing women's health: essential concerns before surgical intervention for gynecological cancer.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Brännlund Hanna, Kähler Pernilla Dahm, Jakobsson Sofie
Аннотация
PURPOSE: To investigate women's health prior to surgical intervention for suspected or confirmed gynecological cancer, with a specific focus on sexual - and mental health.
METHODS: A cross-sectional study including women scheduled for surgery due to gynecological cancer. Patient-reported outcomes were collected at a single time point upon admission to an oncological surgery ward using validated questionnaires (GAD-7, EORTC QLQ CX-24, EQ-5D-5L) and two open-ended questions: "Describe what concerns distress you the most right now?" and "What is most important to you right now?"
RESULTS: Out of 206 eligible patients, 155 (median age 62, range 29-87) completed the questionnaires. All major gynecological cancer types were represented. Most women (76%) underwent minimally invasive surgery, and 31% had benign conditions. Additionally oncological treatment (chemotherapy and/or radiotherapy) was needed in 40% of cases. The mean EQ-5D-5L VAS score was 72 (SD 20), with 35% reporting low preoperative health status (<70). Women with suspected ovarian cancer reported the lowest health status, while those with suspected endometrial cancer reported the highest, though differences between groups were not statistically significant (p = 0.101). Uncertainty prior to diagnosis was a shared concern and affected women's physical, psychological, and sexual well-being. Responses to "What is most important to you right now?" reflected the need for personalized care.
CONCLUSION: Improved long-term survival in gynecological cancers increases the need to address health concerns already prior to surgery. The study highlights the need for a holistic, narrative-based approach in preoperative care to address not only physical symptoms but also emotional, social and existential needs.
THE CLINICAL TRIAL REGISTRATION NUMBER: researchweb.org/project/282380.
METHODS: A cross-sectional study including women scheduled for surgery due to gynecological cancer. Patient-reported outcomes were collected at a single time point upon admission to an oncological surgery ward using validated questionnaires (GAD-7, EORTC QLQ CX-24, EQ-5D-5L) and two open-ended questions: "Describe what concerns distress you the most right now?" and "What is most important to you right now?"
RESULTS: Out of 206 eligible patients, 155 (median age 62, range 29-87) completed the questionnaires. All major gynecological cancer types were represented. Most women (76%) underwent minimally invasive surgery, and 31% had benign conditions. Additionally oncological treatment (chemotherapy and/or radiotherapy) was needed in 40% of cases. The mean EQ-5D-5L VAS score was 72 (SD 20), with 35% reporting low preoperative health status (<70). Women with suspected ovarian cancer reported the lowest health status, while those with suspected endometrial cancer reported the highest, though differences between groups were not statistically significant (p = 0.101). Uncertainty prior to diagnosis was a shared concern and affected women's physical, psychological, and sexual well-being. Responses to "What is most important to you right now?" reflected the need for personalized care.
CONCLUSION: Improved long-term survival in gynecological cancers increases the need to address health concerns already prior to surgery. The study highlights the need for a holistic, narrative-based approach in preoperative care to address not only physical symptoms but also emotional, social and existential needs.
THE CLINICAL TRIAL REGISTRATION NUMBER: researchweb.org/project/282380.